This presentation updates the APN's current knowledge about marijuana and CBD to allow informed dialogue with patients. APNs need to understand the changing landscape around these products with practical knowledge on legal issues, current research, pharmacological actions and effects including safety and efficacy, potential medical uses, and available preparations.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 10/18/22.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil

There are no other Planning Committee disclosures to declare.

Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this education activity, the learner will be able to describe the endocannabinoid system and the pharmacological actions of medical cannabis products along with the appropriate medical uses.